| Description | Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, specifically binds to the cytokine-binding epitope of the human βc receptor with picomolar affinity. It potently inhibits the collective impact of IL-3, GM-CSF, and IL-5 on eosinophil survival, underscoring its potential in chronic inflammatory diseases research [1]. |
| Synonyms | CSL311 |
| molecular weight | N/A |
| CAS | 2643974-98-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |